Condition: Obesity · Sponsor: Novo Nordisk A/S
This observational study will explore how Wegovy® (Semaglutide) is used in everyday situations, how it might affect things like weight, body mass index (BMI) and waist circumference, and what kind of impact it could have on overall quality of life. The overall purpose of this study is to understand how Wegovy impacts weight when used as part of regular medical care. Participants will be treated with Wegovy as prescribed to the participant by their doctor, in accordance with normal clinical practice. The study will last for about two years.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| CAP Sarrià | Barcelona, Spain | — |
| CAP Sants | Barcelona, Spain | — |
| Hospital Vall d'Hebron | Barcelona, Spain | — |
| Centro de Salud Cartagena Casco Antiguo | Cartagena, Spain | — |
| Hospital Vithas Sevilla | Castilleja de la Cuesta, Spain | — |
| Hospital Univ. Virgen de la Arrixaca | El Palmar (Murcia), Spain | — |
| Clínica de Endocrinología y Nutrición Dr. Bellido | Ferrol, Spain | — |
| Ginegetafe S.L. | Getafe (Madrid), Spain | — |
| Centro de Salud La Cuesta | La Cuesta (Santa Cruz de Tenerife), Spain | — |
| Hospital Univ. de Gran Canaria Doctor Negrín | Las Palmas de Gran Canaria, Spain | — |
| Hospital Universitario Sanitas Virgen del Mar | Madrid, Spain | — |
| Hospital Quirónsalud Málaga | Málaga, Spain | — |
+ 18 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.